- For three
months ended August 31, 2018, core investor relations and subscription
sales generated $497,560, or 70 percent of CIIX’s $712,360 total revenue
- Warren
Wang, CEO of CIIX, eyes greater FY2019 distribution of industrial
hemp-based CBD products, both domestically and in China, for CBD Biotech
enterprise
- SeeThruEquity,
LLC, in update, sees CIIX as having upside potential if it can achieve
renewed traction on investor relations and execute on cannabis and
cryptocurrency strategies
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) core businesses
of investor relations and subscriptions drove 70 percent of its 1Q19 revenues,
the company reported. It also had 70 percent higher YOY sales for its first
quarter (http://ibn.fm/niMS4).
At the same time, CIIX sees CBD Biotech, its wholly-owned foreign enterprise,
delivering higher CBD product distribution in FY2019, both domestically and in
China. It also reported an 800 percent increase in product sales led by
ChineseHempOil.com, Inc. in 1Q19.
The CBD division, which includes CBD Biotech, Hemp Logic,
Inc. and ChineseHempOil.com, Inc. (http://ibn.fm/fQa2J), is expected to deliver greater CBD
product distribution due to larger marketing resources supplied by the company
and an improved business, regulatory and political landscape in China, the
company said. Prior, CIIX had also detailed plans to spin off its CBD division
in the future.
CIIX presented at the National Investment Banking
Association (NIBA) investment conference held at the Crowne Plaza Times Square
hotel in New York City on October 31-November 1. It discussed its first quarter
2019 performance.
Wang of CIIX says that the company recorded sales of $2.35
million for FY2018, the 12 months ended May 31, 2018, up 41 percent compared to
the prior year (http://ibn.fm/nO4Hd).
“CBD hemp sales in China continue to be the foundation of
our focus. Our subscription services will continue to provide a steady revenue
stream along with the new educational services covering the cryptocurrency
market.” Wang said in a news release. “With increased marketing resources devoted
to our industrial hemp-based CBD products, we anticipate a productive fiscal
year 2019.”
CIIX in 1Q19 reported a YOY increase of $90,000 from its
subscription revenues. Investor relations and subscriptions represent its
business roots. CIIX is a diverse company with an international audience of
Chinese-speaking investors. It is active in cryptocurrency education and the
cannabis industry.
In an update, SeeThruEquity, LLC projected that CIIX is an
investment opportunity with upside potential, if the company can provide
renewed traction in its high margin investor relations services business and
execute on its initiatives in both cannabis and cryptocurrency (http://ibn.fm/6P9rL).
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
